Etiology, screening, and treatment of hepatocellular carcinoma

Medical Clinics of North America

Volumn 80, Issue 5, 1996, Pages 1121-1145

  Khakoo, S I ^a   Grellier, L F L ^a   Soni, P N ^a   Bhattacharya, S ^a   Dusheiko, G M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACLARUBICIN; ALCOHOL; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CHONDROITIN SULFATE IRON; CISPLATIN; CONTRAST MEDIUM; CYCLOSPORIN A; CYTOTOXIC AGENT; DOXORUBICIN; EPIRUBICIN; FAMCICLOVIR; FERRITIN ANTIBODY I 131; FLUOROURACIL; GELATIN SPONGE; HEPATITIS B ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERFERON; INTERLEUKIN 2; IODINATED POPPYSEED OIL; LAMIVUDINE; MEGLUMINE DIATRIZOATE PLUS SODIUM DIATRIZOATE; MITOMYCIN C; MONOCLONAL ANTIBODY; POLYVINYL ALCOHOL SPONGE; RICIN; STEROID; TAMOXIFEN; TUMOR MARKER; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROGRAFIN 290; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ARTIFICIAL EMBOLISM; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; GRAFT REJECTION; HEPATITIS B; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MULTICENTER STUDY; NONHUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0029774571     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70482-X     Document Type: Article

References (151)

1. S. Arii J. Tanaka Y. Yamazoe Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy Cancer 69 1992 913
2. M.L. Avantaggiati G. Natoli C. Balsano The hepatitis B virus (HBV) pX transactivates the c- fos promoter through multiple cis -acting elements Oncogene 8 1993 1567
3. L. Belli F. Romani L. Belli Reappraisal of surgical treatment of small hepatocellular carcinoma in cirrhosis Dig Dis Sci 34 1989 1571
4. 131iodine-lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma Cancer 76 1995 2202
5. R.J. Blanchard I.M. Morrow J.B. Sutherland Treatment of liver tumours with yttrium-90 microspheres alone Can Assoc Radiol J 40 1989 206
6. C. Brechot Hepatitis B virus (HBV) and hepatocellular carcinoma: HBV DNA status and its implications J Hepatol 4 1987 269
7. J. Bretagne J. Raoul P. Bourguet Hepatic artery injection of I-131 labeled lipiodol Radiology 168 1988 547
8. J.F. Bretagne J.L. Raoul P. Bourguet Hepatic artery injection of I-131-labeled lipiodol: Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases Radiology 168 1988 547
9. J. Bruix J.M. Barrera X. Calvet Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis Lancet 2 1989 1004
10. L.J. Burditt M.M. Johnson P.J. Johnson Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing Cancer 74 1994 25
11. M.A. Burton B.N. Gray P.F. Klemp Selective internal radiation therapy: Distribution of radiation in the liver Eur J Cancer Clin Oncol 25 1989 1487
12. M.T. Carriaga D.E. Henson Liver, gallbladder, extrahepatic bile ducts, and pancreas Cancer Res 75 1995 171
13. F.V. Chisari K. Klopchin T. Moriyama Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice Cell 59 1989 1145
14. A.M. Cochrane I.M. Murray-Lyon D.M. Brinkley Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma Cancer 40 1977 609
15. M. Colombo Hepatocellular carcinoma in cirrhotics Semin Liver Dis 13 1993 374
16. M. Colombo R. De Franchis E. Del Ninno Hepatocellular carcinoma in Italian patients with cirrhosis N Engl J Med 325 1991 675
17. M. Cottone M. Turri M. Caltagirone Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: An 8-year prospective study by ultrasound and alphafetoprotein J Hepatol 21 1994 1029
18. M.S. De Mitri K. Poussin P. Baccarini HCV-associated liver cancer without cirrhosis Lancet 345 1995 413
19. M. De Santis R. Romagnoli A. Cristani MRI of small hepatocellular carcinoma: Comparison with US, CT, DSA, and lipiodol-CT J Comput Assist Tomogr 16 1992 189
20. Y.M. Deugnier P. Charalambous D. Le Quilleuc Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients Hepatology 18 1993 1363
21. S. Ding N.A. Habib Loss of heterozygosity in liver tumours J Hepatol 22 1995 230
22. K. Dowlatshahi A.K. Bhattacharya B. Silver Percutaneous interstitial laser therapy of a patient with recurrent hepatoma in a transplanted liver Surgery 112 1992 603
23. A.A. Dunk S.C. Scott P.J. Johnson Mitozantrone as single agent therapy in hepatocellular carcinoma: A phase II study J Hepatol 1 1985 395
24. F. Durand C. Buffet G. Pelletier Screening of hepatocellular carcinoma in French patients Dig Dis Sci 40 1995 706
25. G.M. Dusheiko J.C. Conradie S.M. Bowyer Small and asymptomatic HCC detected by alpha-fetoprotein screening in black hepatitis B carriers S Afr Med J 69 1986 129
26. Editorial: Lipiodol computed tomography for small hepatocellular carcinomas Lancet 337 1991 333
27. G.J. Ehrhardt D.E. Day Therapeutic use of 90Y microspheres Int J Radiat Appl Instr Nucl Med Biol 14 1987 233
28. P.F. Engstrom B. Levin C.G. Moertel A phase II trial of tamoxifen in hepatocellular carcinoma Cancer 65 1990 2641
29. B. Epstein D. Ettinger P.K. Leichner Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma Cancer 67 1991 896
30. S. Erikkson J. Carlson R. Velez Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency N Engl J Med 314 1986 736
31. G. Falkson A. Cnaan A. Schutt Prognostic factors for survival in hepatocellular carcinoma Cancer Res 48 1988 7314
32. S. Fargion C. Mandelli A. Piperno Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis Hepatology 15 1992 655
33. S. Fargion A. Piperno M.D. Cappellini Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association Hepatology 16 1992 1322
34. D. Franco L. Capussotti C. Smadja Resection of hepatocellular carcinomas: Results in 72 European patients with cirrhosis Gastroenterology 98 1990 733
35. T. Furuta T. Kanematsu T. Matsumata Lipiodolization prolongs survival rates in postoperative patients with a recurrent hepatocellular carcinoma Hepatogastroenterology 37 1990 494
36. L. Gandolfi L. Solmi G.C. Pizza Intratumoral echo-guided injection of interleukin-2 and lymphokine-activated killer cells in hepatocellular carcinoma Hepatogastroenterology 36 1989 352
37. A.L. Gerbes W.H. Caselmann Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins J Hepatol 19 1995 312
38. J.C. Gilbert G.M. Onik W.K. Hoddick Real time ultrasonic monitoring of hepatic cryosurgery Cryobiology 22 1985 319
39. M. Hanss C. Bonvoisin B. Patouillard Increased plasma levels of urokinase type plasminogen activator during hepatocellular carcinoma Fibrinolysis 8 1994 255
40. M.J. Herba F.F. Illescas M.P. Thirlwell Hepatic malignancies: Improved treatment with intraarterial Y-90 Radiology 169 1988 311
41. W. Heyward A. Lanier M. Fitzgerald Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein among persons infected with hepatitis B virus JAMA 254 1985 3052
42. S. Houle T.K. Yip F.A. Shepherd Hepatocellular carcinoma: Pilot trial of treatment with Y-90 microspheres Radiology 172 1989 857
43. S. Huang F.V. Chisari Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice Hepatology 21 1995 620
44. A. Ido K. Nakata Y. Kato Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter Cancer Res 55 1995 3105
45. S. Imaoka Y. Sasaki T. Shibata A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma Cancer Chemother Pharmacol 23 1988 126
46. K. Iwai H. Maeda T. Konno Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image Cancer Res 44 1984 2115
47. S. Iwatsuki T.E. Starzl D.G. Sheahan Hepatic resection versus transplantation for hepatocellular carcinoma Ann Surg 214 1991 221
48. J.E. Jackson E.Y. Yeung P. McCarthy Lipiodol retention at the site of liver biopsy: A false positive result in the investigation of hepatocellular carcinoma Clin Radiol 40 1989 538
49. T.G. John O.J. Garden Needle track seeding of primary and secondary liver carcinoma after percutaneous liver biopsy HPB Surg 6 1993 199
50. P.J. Johnson C. Kalayci N. Dobbs Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodol J Hepatol 13 1991 120
51. C. Kalayci P.J. Johnson N. Raby Intra-arterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: A comparison with intravenous adriamycin J Hepatol 11 1990 349
52. M. Kamba Y. Suto T. Kato Chondroitin sulfate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma: Comparison with CT during arterial portography Acta Radiol 35 1994 570
53. J. Kanematsu J. Furuta K. Takenaka A five year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma Hepatology 10 1989 98
54. A. Kasahara N. Hayashi H. Fusamoto Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes Dig Dis Sci 38 1993 2170
55. H. Kasugai J. Kojima M. Tatsuta Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil Gastroenterology 97 1989 965
56. K.N. Khan K. Nakata Y. Kusumoto Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma Cancer Res 51 1991 5667
57. H. Kobayashi H. Hidaka Y. Kajiya Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution Acta Radiol Diag 27 1986 139
58. S. Kondo M. Nishikawa S. Takami Diagnostic value of lipiodol injection in focal nodular hyperplasia of the liver Am J Gastroenterol 86 1991 779
59. T. Konno H. Maeda K. Iwai Selective targeting of anticancer drug and simultaneous image enhancement in solid tumours by arterially administered lipid contrast medium Cancer 54 1984 2367
60. 2 microbubbles Radiology 182 1992 155
61. C. Kuroda M. Sakurai M. Monden Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma: A study in resected cases Cancer 67 1991 81
62. C.L. Lai J.Y.N. Lau P.C. Wu Subclinical hepatocellular carcinoma in Hong Kong Chinese Oncology (Basel) 49 1992 347
63. C.L. Lai P.C. Wu A.S. Lok Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: A prospective randomised trial Br J Cancer 60 1989 928
64. E.C. Lai I.O. Ng M.M. Ng Long-term results of resection for large hepatocellular carcinoma: A multivariate analysis of clinicopathological features Hepatology 11 1990 815
65. E.C.S. Lai I.O.L. Ng K.T. You Hepatic resection for small hepatocellular carcinoma: The Queen Mary Hospital experience World J Surg 15 1991 654
66. W. Lauchart R. Muller R. Pichlmayr Immunoprophylaxis of hepatitis B viral reinfection in recipients of human liver allografts Transpl Proc 19 1991 2387
67. B. Le Bail H. Jouhanole Y. Deugnier Liver adenomatosis with granulomas in two patients on long-term oral contraceptives Am J Surg Pathol 16 1992 982
68. J. Limmer W.E. Fleig D. Leupold Hepatocellular carcinoma in type I glycogen storage disease Hepatology 8 1988 531
69. D.Y. Lin Y.F. Liaw T.Y. Lee Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma—a randomized controlled trial Gastroenterology 94 1988 453
70. T. Livraghi L. Bolondi L. Buscarini No treatment, resection and ethanol injection in hepatocellular carcinoma: A retrospective analysis of survival in 391 patients with cirrhosis J Hepatol 22 1995 522
71. T. Livraghi L. Bolondi S. Lazzaroni Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: A study on 207 patients Cancer 69 1992 925
72. M.T. Madsen C.H. Park M.L. Thakur Dosimetry of iodine-131 ethiodol in the treatment of hepatoma J Nucl Med 29 1988 1038
73. R. Maraj M.C. Kew R.J. Hyslop Resectability rate of hepatocellular carcinoma in rural southern Africans Br J Surg 75 1988 335
74. N. Markham A. Ritson O. James Primary hepatocellular carcinoma localised by a radiolabelled monoclonal antibody J Hepatol 2 1986 25
75. 1 Proc Natl Acad Sci USA 92 1995 2384
76. V.M. Meade M.A. Burton B.N. Gray Distribution of different sized microspheres in experimental hepatic tumours Eur J Cancer Clin Oncol 23 1987 37
77. W. Melia M. Wilkinson B. Portmann Hepatocellular carcinoma in the noncirrhotic liver: A comparison with that complicating cirrhosis Q J Med 211 1984 391
78. J. Michel B. Suc G. Fourtanier Recurrence of hepatocellular carcinoma in cirrhotic patients after liver resection or transplantation Transplant Proc 27 1995 1798
79. T. Murakami T. Kim H. Oi Detectability of hypervascular hepatocellular carcinoma by arterial phase images of MR and spiral CT Acta Radiol 36 1995 372
80. Y. Murakami K. Hayashi S. Hirohashi Aberrations of the tumour suppressor p53 and Rb genes in human hepatocellular carcinoma Cancer Res 51 1991 5520
81. R. Naccarto F. Farinati Hepatocellular carcinoma, alcohol, and cirrhosis: Fact and hypothesis Dig Dis Sci 36 1991 1137
82. K. Nakakuma S. Tashiro K. Uemura Studies on anticancer treatment with an oily anticancer drug injected into the ligated hepatitic artery for liver cancer Nichidoku Iho 24 1979 675
83. N. Nakao K. Kamino K. Miura Recurrent hepatocellular carcinoma after partial hepatectomy: Value of treatment with transcatheter arterial chemoembolization AJR Am J Roentgenol 156 1991 1177
84. K.B. Nakhgevany J. Mobini J.G. Bassett Nonabsorbable radioactive material in the treatment of carcinomas by local injections Cancer 61 1988 931
85. G. Natoli M.L. Avantaggiati P. Chirillo Induction of the DNA-binding activity of c-Jun/c-Fos heterodimers by the hepatitis B virus transactivator pX Mol Cell Biol 14 1994 989
86. G. Natoli M.L. Avantaggiati P. Chirillo Modulation of intracellular signal transduction pathways by the hepatitis B virus transactivator pX J Hepatol 22 suppl 1 1995 14
87. H. Ngan Lipiodol computerized tomography: How sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? Br J Radiol 63 1990 771
88. C. Niederau R. Fischer A. Sonnenberg Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis N Engl J Med 313 1995 1256
89. S. Nishiguchi T. Kuroki S. Nakatani Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis Lancet 346 1995 1051
90. J.R. Novell G. Dusheiko N.I. Markham Selective regional chemotherapy of unresectable hepatic tumours using lipiodol HPB Surg 4 1991 223
91. R.G. Novell G.M. Dusheiko Hepatocellular carcinoma: local and regional therapies E. Tabor A. DiBisceglie R.H. Purcell Etiology, Pathology and Treatment of Hepatocellular Carcinoma in North America 1991 Portfolio Houston 317
92. R. Novell A. Hilson K. Hobbs Ablation of recurrent primary liver cancer using 131I-lipiodol Postgrad Med J 67 1991 393
93. J.G. O'Grady R.J. Polson K. Rolles Liver transplantation for malignant disease: Results in 93 consecutive patients Ann Surg 207 1988 373
94. H. Ohishi H. Uchida H. Yoshimura Hepatocellular carcinoma detected by iodized oil: Use of anticancer agents Radiology 154 1985 25
95. K. Ohtomo Y. Itai Imaging of hepatocellular carcinoma Dig Surg 12 1995 22
96. K. Okuda T. Ohtsuki H. Obata Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients Cancer 56 1985 918
97. K.M. Olthoff M.H. Rosove C.R. Shackleton Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma Ann Surg 221 1995 734
98. S.E. Order G.B. Stillwagon J.L. Klein Iodine 131 antiferritin, a new treatment modality in hepatoma: A Radiation Therapy Oncology Group study J Clin Oncol 3 1985 1573
99. Ozturk M. Collaborators p53 mutation in hepatocellular carcinoma after aflatoxin exposure Lancet 338 1991 1356
100. C. Park S.I. Choi H. Kim Distribution of lipiodol in hepatocellular carcinoma Liver 10 1990 72
101. C.H. Park J.H. Suh H.S. Yoo Treatment of hepatocellular carcinoma (HCC) with radiolabeled lipiodol: A preliminary report Nucl Med Commun 8 1987 1075
102. P. Paterlini K. Poussin M. Kew Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma Hepatology 21 1995 313
103. D. Pateron N. Ganne J.C. Trinchet Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis J Hepatol 20 1994 65
104. Y.Z. Patt L. Claghorn C. Charnsangavej Hepatocellular carcinoma: A retrospective analysis of treatments to manage disease confined to the liver [review] Cancer 61 1988 1884
105. I. Penn Hepatic transplantation for primary and metastatic cancers of the liver Surgery 110 1991 726
106. C. Qian R. Bilbao O. Brun˜a Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase Hepatology 22 1995 118
107. J.L. Raoul P. Bourguet J.F. Bretagne Hepatic artery injection of I-131-labeled lipiodol: Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases Radiology 168 1988 541
108. J.I. Raoul J.F. Bretagne J.P. Caucanas Internal radiation therapy for hepatocellular carcinoma: Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled lipiodol Cancer 69 1992 346
109. T.S. Ravikumar R. Kane B. Cady A 5-year study of cryosurgery in the treatment of liver tumors Arch Surg 126 1991 1520
110. M. Renner A. Haniel E. Bürgelt Transactivating function and expression of the x gene of hepatitis B virus J Hepatol 23 1995 53
111. D. Samuel R. Muller G. Alexander EUROHEP Study Liver transplantation in European patients with hepatitis B surface antigen N Engl J Med 329 1993 1842
112. A. Scholz M. Langer R. Langer Intra-arterial chemoembolization of non-resectable hepatocellular carcinoma ROFO 154 1991 258
113. M.E. Schwartz Primary hepatocellular carcinoma: Transplant versus resection Semin Liver Dis 14 1994 135
114. H.K. Seitz A.J. Garro C.S. Lieber Sex dependent effect of chronic ethanol consumption in rats on hepatic microsome mediated mutagenicity of benzo(a)pyrene Cancer Lett 13 1981 97
115. M. Sherman K.M. Peltekian C. Lee Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population Hepatology 22 1995 432
116. J.C. Sheu G.T. Huang D.S. Chen Small hepatocellular carcinoma: Intratumor ethanol treatment using new needle and guidance systems Radiology 163 1987 43
117. J.C. Sheu J.L. Sung D.S. Chen Early detection of hepatocellular carcinoma by real-time ultrasonography: A prospective study Cancer 56 1985 660
118. S. Shiina K. Tagawa Y. Niwa Percutaneous ethanol injection therapy for hepatocellular carcinoma: Results in 146 patients AJR Am J Roentgenol 16 1993 1023
119. K. Shimamoto S. Sakuma T. Ishigaki Hepatocellular carcinoma: Evaluation with color Doppler US and MR imaging Radiology 182 1992 149
120. K. Shirabe T. Kanematsu T. Matsumata Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analysis Hepatology 14 1991 802
121. K. Shiraki K. Takase Y. Tameda A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients Hepatology 22 1995 802
122. K.S. Song A. Lee J.R. Choi Diagnostic efficacy of plasma urokinase-type plasminogen activator and plasminogen activator inhibitor-2 in differentiation of hepatocellular carcinoma from cirrhosis Thromb Haemost 74 1995 864
123. M.J. Stone G.B.G. Klintmalm D. Polter Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: A pilot study in 20 patients Gastroenterology 104 1993 196
124. Y. Suto F. Kodama M. Kamba Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma Acta Radiol 36 1995 102
125. S. Takano O. Yokosuka F. Imazeki Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients Hepatology 21 1995 650
126. K. Takayasu H. Furukawa F. Wakao CT diagnosis of early hepatocellular carcinoma: Sensitivity, findings, and CT-pathologic correlation AJR Am J Roentgenol 164 1995 885
127. K. Takayasu N. Moriyama Y. Muramatsu The diagnosis of small hepatocellular carcinomas: Efficacy of various imaging procedures in 100 patients AJR Am J Roentgenol 155 1990 49
128. K. Takayasu Y. Muramatsu N. Moriyama Clinical and radiologic assessments of the results of hepatectomy for small hepatocellular carcinoma and therapeutic arterial embolization for postoperative recurrence Cancer 64 1989 1848
129. K. Takayasu Y. Shima Y. Muramatsu Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents Radiology 163 1987 345
130. K.C. Tan M. Rela S.D. Ryder Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis Br J Surg 82 1995 253
131. Z. Tang Y. Yu X. Zhou Surgery of small hepatocellular carcinoma: Analysis of 144 cases Cancer 64 1989 536
132. The Liver Cancer Study Group of Japan Primary liver cancer in Japan Ann Surg 211 1989 277
133. D.G. Tiniakos G.N. Tiniakos The role of oncogenes and tumour-suppressor genes in aetiopathogenesis of human hepatocellular carcinoma G.N. Tiniakos Progress in Hepatology 1994 1994 BETA Medical Publishers Ltd Athens 105
134. T. Tokino K. Matsubara Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma J Virol 65 1991 6761
135. R. Truant J. Antunovic J. Greenblatt Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation J Virol 69 1995 1851
136. H. Tsukuma T. Hiyama S. Tanaka Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1993 1797
137. T. Tsuzuki A. Sugioka M. Ueda Hepatic resection for hepatocellular carcinoma Surgery 107 1990 511
138. J.-S. Twu M.-Y. Lai D.-S. Chen Activation of protooncogene C- jun by the X protein of hepatitis B virus Virology 192 1993 346
139. D. Vetter J.J. Wenger J.M. Bergier Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a Western comparative study in 60 patients Hepatology 13 1991 427
140. J.T. Wang T.H. Wang J.T. Lin Hepatitis C virus in a prospective study of posttransfusion non-A, non-B hepatitis in Taiwan J Med Virol 32 1990 83
141. H.C. Whittle N. Maine J. Pilkington Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages Lancet 345 1995 1089
142. I. Wollner C. Knutsen P. Smith Effects of hepatic arterial yttrium 90 glass microspheres in dogs Cancer 61 1988 1336
143. W.C.W. Wong K.K. Tsang A mass hepatitis B vaccination programme in Taiwan: Its preparation, results and reasons for uncompleted vaccinations Vaccine 12 1994 229
144. H. Yamamoto Y. Yamashita S. Yoshimatsu Hepatocellular carcinoma in cirrhotic livers: Detection with unenhanced and iron oxide-enhanced MR imaging Radiology 195 1995 106
145. M. Yamauchi M. Nakahara Y. Maezawa Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C Am J Gastroenterol 88 1993 39
146. I. Yokoyama D.G. Sheahan B. Carr Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma Transplant Proc 23 1991 2194
147. H.S. Yoo J.T. Lee K.W. Kim Nodular hepatocellular carcinoma: Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil Cancer 68 1991 1878
148. Y. Yumoto K. Jinno K. Tokuyama Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma Int J Hyperther 7 1991 7
149. S.N. Zaman P.J. Johnson R. Williams Silent cirrhosis in patients with hepatocellular carcinoma: Implications for screening in high-incidence and low-incidence areas Cancer 65 1990 1607
150. A.L. Zerbey P.R. Mueller S.L. Dawson Pleural seeding from hepatocellular carcinoma: A complication of percutaneous alcohol ablation Radiology 193 1994 81
151. X. Zhou Z. Tang Y. Yu Solitary minute hepatocellular carcinoma: A study of 14 patients Cancer 67 1991 2855